Modelling the effect of laminar axially directed blood flow on the dissolution of non-occlusive blood clots

Physics in Medicine and Biology

Volumn 52, Issue 11, 2007, Pages 2969-2985

  Sersa I ^a   Vidmar, J ^a   Grobelnik, B ^a   Mikac, U ^a   Tratar, G ^b   Blinc, A ^b  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CHANNEL FLOW; MAGNETIC RESONANCE MEASUREMENT; MATHEMATICAL MODELS; MEDICAL IMAGING; TWO DIMENSIONAL; VISCOUS FLOW;

BLOOD CLOTS; BLOOD FLOW; MAGNETIC RESONANCE (MR) MICROSCOPY; RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR (RT-PA); THROMBOLYSIS;

PLASMA (HUMAN);

ALTEPLASE; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ARTICLE; BLOOD CLOT; BLOOD CLOT LYSIS; BLOOD FLOW; BLOOD FLOW VELOCITY; DISSOLUTION; EXTRACORPOREAL CIRCULATION; HUMAN; IN VITRO STUDY; LAMINAR FLOW; MALE; MATHEMATICAL MODEL; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SHEAR FLOW; STATISTICAL SIGNIFICANCE; THROMBOSIS; VASOCONSTRICTION; VISCOSITY;

BLOOD COAGULATION; BLOOD FLOW VELOCITY; CONTRAST MEDIA; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MODELS, ANATOMIC; MODELS, STATISTICAL; MODELS, THEORETICAL; RECOMBINANT PROTEINS; STRESS, MECHANICAL; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 34249016697     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/52/11/003     Document Type: Article

References (41)

1. Anand S and Diamond S L 1996 Computer simulation of systemic circulation and clot lysis dynamics during thrombolytic therapy that accounts for inner clot transport and reaction Circulation 94 763-74
2. Anand S, Kudallur V, Pitman E B and Diamond S L 1997 Mechanisms by which thrombolytic therapy results in nonuniform lysis and residual thrombus after reperfusion Ann. Biomed. Eng. 25 964-74
3. Anderson J D 1995 Computational Fluid Dynamics: The Basics with Applications (New York: McGraw-Hill)
4. Blinc A and Francis C W 1996 Transport processes in fibrinolysis and fibrinolytic therapy Thromb. Haemost. 76 481-91
5. Blinc A, Francis C W, Trudnowski J L and Carstensen E L 1993 Characterization of ultrasound-potentiated fibrinolysis in vitro Blood 81 2636-43
6. Blinc A, Keber D, Lahajnar G, Zupancic I, Zorec-Karlovsek M and Demsar F 1992 Magnetic resonance imaging of retracted and nonretracted blood clots during fibrinolysis in vitro Haemostasis 22 195-201
7. Carr M E, Shen L L and Hermans J 1977 Mass-length ratio of fibrin fibbers from gel permeation and light scattering Biopolymers 16 1-15
8. Clark W M, Wissman S, Albers G W, Jhamandas J H, Madden K P and Hamilton S 1999 Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3-5 h after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke JAMA 282 2019-26
9. Colebrook C F 1938 Turbulent flow in pipes J. Inst. Civil. Eng. 11 133
10. Collen D 1999 The plasminogen (fibrinolytic) system Thromb. Haemost. 82 259-70
11. Diamond S L and Anand S 1993 Inner clot diffusion and permeation during fibrinolysis Biophys. J. 65 2622-43
12. Dryden H L, Murnaghan F P and Bateman H 1956 Hydrodynamics (New York: Dover)
13. Faber T E 1995 Fluid Dynamics for Physicists (New York: Cambridge University Press)
14. Goldhaber S Z et al 1993 Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion Lancet 341 507-11
15. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico 1990 GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction Lancet 336 65-71
16. Haacke E M, Brown R W, Thompson M R and Venkatesan R 1999 Magnetic Resonance Imaging: Physical Principles and Sequence Design (New York: Wiley-Liss Publication) pp 703-40
17. Hill M D and Buchan A M 2005 Canadian Alteplase for Stroke Effectiveness Study (CASES) investigators. thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study CMAJ 172 1307-12
18. Kavanau J L 1950 Enzyme kinetics and the rate of biological processes J. Gen. Physiol. 34 193-209
19. Konstantinides S, Geibel A, Heusel G, Heinrich F and Kasper W 2002 Management strategies and prognosis of pulmonary embolism-3 trial investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism N. Engl. J. Med. 347 1143-50
20. Marder V J, Landskroner K, Novokhatny V, Zimmerman T P, Kong M, Kanouse J J and Jesmok G 2001 Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit Thromb. Haemost. 86 739-45
21. Nichols W W and O'Rourke M F 2005 McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles 5th edn (London: Hodder Arnold)
22. Ouriel K, Castaneda F, McNamara T, Swischuk J, Tepe G, Smith J J, Clark J and Duda S 2004 Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: results from the RELAX trial J. Vasc. Interv. Radiol. 15 229-38
23. Ouriel K, Veith F J and Sasahara A A 1998 A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) investigators N. Engl. J. Med. 338 1105-11
24. Pleydell C P, David T, Smye S W and Berridge D C 2002 A mathematical model of post-canalization thrombolysis Phys. Med. Biol. 47 209-24
25. Press W H, Flannery B P, Teukolsky S A and Vetterling W T 1989 Numerical Recipes in Pascal (Cambridge: Cambridge University Press) pp 673-726
26. Šabovič M, Lijnen H R, Keber D and Collen D 1989 Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators Thromb. Haemost 62 1083-7
27. Šabovič M, Lijnen H R, Keber D and Collen D 1990 Correlation between progressive adsorption of plasminogen to blood clots and their sensitivity to lysis Thromb. Haemost. 64 450-4
28. Sakharov D V and Rijken D C 2000 The effect of flow on lysisis of plasma clots in a plasma environment Thromb. Haemost. 83 469-74
29. Schiller L 1922 Studies of laminar and turbulent flow Phys. Z. 23 14-9
30. Sekoranja L, Loulidi J, Yilmaz H, Lovblad K, Temperli P, Comelli M and Sztajzel R F 2006 Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography-guided pilot study Stroke 37 1805-9
31. Serša I, Tratar G and Blinc A 2005 Blood clot dissolution dynamics simulation during thrombolytic therapy J. Chem. Inf. Mod. 45 1686-90
32. Spohr F et al 2005 International multicentre trial protocol to assess the efficacy and safety of tenecteplase during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest: the Thrombolysis in Cardiac Arrest (TROICA) Study Eur. J. Clin. Invest. 35 315-23
33. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators 1997 A comparison of reteplase with alteplase for acute myocardial infarction N. Engl. J. Med. 337 1118-23
34. The GUSTO Investigators 1993 An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N. Engl. J. Med. 329 673-82
35. The ISIS-2 Investigators (Second International Study of Infarct Survival) Collaborative Group 1988 Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction J. Am. Coll. Cardiol. 12 (6 Suppl. A) 3A-13A
36. Torr S R, Nachowiak D A, Fujii S and Sobel B E 1992 Plasminogen steal and clot lysis J. Am. Coll. Cardiol. 19 1085-90
37. Tratar G, Blinc A, Štrukelj M, Mikac U and Serša I 2004 Rapid tangential flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro Thromb. Haemost. 91 487-96
38. Wootton D, Popel A S and Alevriadou B R 2002 An experimental and theoretical study of the dissolution of mural fibrin clots by tissue-type plasminogen activator Biotechnol. Bioeng. 77 405-19
39. Yenari M A, Palmer J T, Bracci P M and Steinberg G K 1995 Thrombolysis with tissue plasminogen activator (tPA) is temperature dependent Thromb. Res. 5 475-81
40. Zidanšek A and Blinc A 1991 The influence of transport parameters and enzyme kinetics of the fibrinolytic system on thrombolysis: mathematical modelling of two idealised cases Thromb. Haemost. 65 553-9
41. Zidanšek A, Blinc A, Lahajnar G, Keber D and Blinc R 1995 Finger-like patterns of blood clots Biophys. J. 69 803-9